Quarterly Result14 Aug 2025, 05:23 pm
Glenmark Pharmaceuticals Reports Q1 2025 Results with Profit of INR 3,302.26 Million
AI Summary
Glenmark Pharmaceuticals Ltd. has reported its unaudited financial results for the first quarter ended 30th June, 2025. The company's total income stands at INR 24,642.63 million, with a profit before tax of INR 4,011.65 million. The board has approved the results in a meeting that commenced at 02:00 p.m. and ended at 04:11 p.m. The results are available on the company's website.
Key Highlights
- Glenmark Pharmaceuticals reports a profit of INR 3,302.26 million for Q1 2025
- Total income stands at INR 24,642.63 million
- Profit before tax is INR 4,011.65 million
- Board meeting held to approve the results
- Results available on the company's website